Agonists of guanylate cyclase useful for the treatment of opioid induced dysfunctions
作者： Kunwar Shailubhai , Vaseem Palejwala
DOI:
关键词:
摘要: This invention provides a method to prevent, control, and/or treat opioid induced dysfunctions comprising administering patient in need guanylate cyclase receptor agonist (GCRA) peptide. Compositions peptides, methods of making, and treatment are also disclosed.
lens.org 参考文章(112)
Kunwar Shailubhai, Therapeutic applications of guanylate cyclase-C receptor agonists. Current Opinion in Drug Discovery & Development. ,vol. 5, pp. 261- ,(2002)
Rajan Bawa, Sustained-release formulation containing and amino acid polymer ,(1985)
Evelyne Vuaridel, Piero Orsolini, Microparticles of biodegradable polymer encapsulating a biologically active substance and sustained release pharmaceutical formulations containing same ,(2002)
Peter E. Daddona, Liang C. Dong, Anthony C. Chao, Si-Hong Alicia Yum, Vu A. Nguyen, Patrick S. L. Wong, Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules ,(2002)
Elka Touitou, John D. Davis, Ardon Rubinstein, Targeted enternal delivery system ,(1986)
Felix Theeuwes, David Edgren, Patrick S. L. Wong, Device for delivering drug to certain pH environments ,(1983)
William Stern, James P. Gilligan, Oral salmon calcitonin pharmaceutical products ,(1996)
Hassan Mohammad, Gastroretentive drug delivery system comprising an extruded hydratable polymer ,(2003)
Michael J. Hageman, Sustained-release protein formulations ,(1993)
Andrew Turner, Homayoun Sadeghi, Christopher P. Prior, Oral delivery of modified transferrin fusion proteins ,(2003)